These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
50 related items for PubMed ID: 5931053
1. [Influence of various disintegrants on the manufacture and preservation of tablets]. Delonca H, Puech A, Delonca M, Nguyen Van Doi. J Pharm Belg; 1966; 21(1):67-72. PubMed ID: 5931053 [No Abstract] [Full Text] [Related]
2. Effect of various disintegrants on the availability of directly compressed sulphadimidine tablets. Aboutaleb AE, Attia AM, Habib FS. Pharmazie; 1983 Jul; 38(7):473-5. PubMed ID: 6634914 [Abstract] [Full Text] [Related]
3. Production of effervescent tablets Mucomali from polysaccharides of Malva Silvestris L. Getia M, Murtazashvili M, Bakuridze A, Jokhadze M, Kuchukhidze J. Georgian Med News; 2007 Apr; (145):90-4. PubMed ID: 17525511 [Abstract] [Full Text] [Related]
4. [Study of the swelling power of tablet disintegrants]. Modrzejewski F, Wochna L. Acta Pol Pharm; 1965 Apr; 22(4):305-10. PubMed ID: 5865098 [No Abstract] [Full Text] [Related]
5. Effects of starches on the mechanical properties of paracetamol tablet formulations. II. Sorghum and plantain starches as disintegrants. Alebiowu G, Itiola OA. Acta Pharm; 2003 Dec; 53(4):313-20. PubMed ID: 14769238 [Abstract] [Full Text] [Related]
6. Interaction of tablet disintegrants and magnesium stearate during mixing. II. Effect on dissolution rate. Lerk CF, Bolhuis GK, Smallenbroek AJ, Zuurman K. Pharm Acta Helv; 1982 Dec; 57(10-11):282-6. PubMed ID: 7146030 [No Abstract] [Full Text] [Related]
7. Cyclodextrin polymer, a new tablet disintegrating agent. Fenyvest E, Antal B, Zsadon B, Szejtli J. Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226 [Abstract] [Full Text] [Related]
8. Influence of starch steeping period on dimensionless disintegration values of a paracetamol tablet formulation. Alebiowu G, Adeyemi AO. Acta Pol Pharm; 2009 Jul; 66(3):311-20. PubMed ID: 19645332 [Abstract] [Full Text] [Related]
9. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex. Piao ZZ, Lee MK, Lee BJ. Int J Pharm; 2008 Feb 28; 350(1-2):205-11. PubMed ID: 17928177 [Abstract] [Full Text] [Related]
10. Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour. Cabri W, Ghetti P, Alpegiani M, Pozzi G, Justo-Erbez A, Pérez-Martínez JI, Villalón-Rubio R, Monedero-Perales MC, Muñoz-Ruiz A. Eur J Pharm Biopharm; 2006 Oct 28; 64(2):212-21. PubMed ID: 16846727 [Abstract] [Full Text] [Related]
11. [Study of polymorphous transformations of sulfanilamide during table manufacture (author's transl)]. Cruaud O, Duchêne D, Puisieux F, Chauvet A, Masse J. J Pharm Belg; 1981 Oct 28; 36(1):15-20. PubMed ID: 7229900 [No Abstract] [Full Text] [Related]
12. [Release of the active agent from matrix tablets with mastix as the base substance]. Georgarakis M, Georgakopoulos PP. Pharmazie; 1984 Mar 28; 39(3):186-7. PubMed ID: 6728892 [No Abstract] [Full Text] [Related]
13. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Fukuda M, Peppas NA, McGinity JW. Int J Pharm; 2006 Mar 09; 310(1-2):90-100. PubMed ID: 16413153 [Abstract] [Full Text] [Related]
14. [Compressibility of directly compressed forms of lactitol]. Muzíková J. Ceska Slov Farm; 2003 Sep 09; 52(5):241-3. PubMed ID: 14619701 [Abstract] [Full Text] [Related]
15. Determining drug spatial distribution within controlled delivery tablets using MFX imaging. Rigby SP, Van der Walle CF, Raistrick JH. J Control Release; 2004 Apr 16; 96(1):97-100. PubMed ID: 15063032 [Abstract] [Full Text] [Related]
16. Abrasion of tablets during scale-up: the influence of different crushing forces in laboratory and production perforated pan coaters. Mueller R, Kleinebudde P. Eur J Pharm Biopharm; 2007 Sep 16; 67(2):458-63. PubMed ID: 17475452 [Abstract] [Full Text] [Related]
17. The manufacture and characterisation of hot-melt extruded enteric tablets. Andrews GP, Jones DS, Diak OA, McCoy CP, Watts AB, McGinity JW. Eur J Pharm Biopharm; 2008 May 16; 69(1):264-73. PubMed ID: 18164604 [Abstract] [Full Text] [Related]
18. Influence of compression forces on tablets disintegration by AC Biosusceptometry. Corá LA, Fonseca PR, Américo MF, Oliveira RB, Baffa O, Miranda JR. Eur J Pharm Biopharm; 2008 May 16; 69(1):372-9. PubMed ID: 18164605 [Abstract] [Full Text] [Related]
19. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets]. Dvorácková K, Rabisková M, Masteiková R, Vocilková L. Ceska Slov Farm; 2007 Jun 16; 56(3):129-34. PubMed ID: 17867525 [Abstract] [Full Text] [Related]
20. [On the polymorphism of barbiturates in powders and tablets. 6: Properties and behaviour of a spray-dried barbital preparation]. Matzkó-Hollenbach K, Pintye-Hódi K, Kedvessy G. Pharmazie; 1982 Aug 16; 37(8):562-5. PubMed ID: 7146063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]